These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29768945)

  • 1. Pharmacist Impact on Treatment Intensification and Hemoglobin A
    Cowart K; Sando K
    J Pharm Pract; 2019 Dec; 32(6):648-654. PubMed ID: 29768945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of Pharmacist-Physician Collaborative Care on Therapeutic Inertia in Patients With Type 2 Diabetes.
    Cowart K; Emechebe N; Pathak R; Abbruzese L; Hann J; Lloyd A; Roetzheim R; Zgibor J; Updike WH
    Ann Pharmacother; 2022 Feb; 56(2):155-161. PubMed ID: 34105397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis.
    Ruiz-Negrón N; Wander C; McAdam-Marx C; Pesa J; Bailey RA; Bellows BK
    J Manag Care Spec Pharm; 2019 Mar; 25(3):304-313. PubMed ID: 30816810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
    Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
    J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
    Chung N; Rascati K; Lopez D; Jokerst J; Garza A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home.
    Prudencio J; Cutler T; Roberts S; Marin S; Wilson M
    J Manag Care Spec Pharm; 2018 May; 24(5):423-429. PubMed ID: 29694290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes.
    Sherrill CH; Houpt CT; Dixon EM; Richter SJ
    J Manag Care Spec Pharm; 2020 May; 26(5):600-609. PubMed ID: 32347180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical inertia among health care providers in a public health safety-net clinic in the management of type 2 diabetes.
    Lingow SE; Guyton JE
    J Am Pharm Assoc (2003); 2020; 60(5):734-739. PubMed ID: 32280024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Effect of Pharmacist Care on Diabetes-Related Outcomes in a Rural Outpatient Clinic: A Retrospective Case-Control Study.
    Moreau C; Sando KR; Zambrano DH
    Ann Pharmacother; 2017 Jun; 51(6):473-478. PubMed ID: 28064508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of clinical inertia in people with diabetes within primary care.
    Meredith AH; Buatois EM; Krenz JR; Walroth T; Shenk M; Triboletti JS; Pence L; Gonzalvo JD
    J Eval Clin Pract; 2021 Apr; 27(2):365-370. PubMed ID: 32548871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Nguyen T; Tao L; Hirsch JD
    Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Clinical Pharmacist Intervention on Hemoglobin A1C Reduction in Veteran Patients With Type 2 Diabetes in a Rural Setting.
    Sullivan J; Jett BP; Cradick M; Zuber J
    Ann Pharmacother; 2016 Dec; 50(12):1023-1027. PubMed ID: 27497068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical inertia in type 2 diabetes: A retrospective analysis of pharmacist-managed diabetes care vs. usual medical care.
    Yam FK; Adams AG; Divine H; Steinke D; Jones MD
    Pharm Pract (Granada); 2013 Oct; 11(4):203-10. PubMed ID: 24367460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-centered medical home pharmacists' impact on composite quality care measures for patients with uncontrolled type 2 diabetes.
    Schwenka N; Donovan A; Franck L; Coan C; McAdam-Marx C; Shin E
    J Am Pharm Assoc (2003); 2023; 63(5):1545-1552.e4. PubMed ID: 37301508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care.
    Salvo MC; Brooks AM
    Ann Pharmacother; 2012 Jan; 46(1):29-34. PubMed ID: 22202497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTING.
    Lin J; Zhou S; Wei W; Pan C; Lingohr-Smith M; Levin P
    Endocr Pract; 2016 Feb; 22(2):151-61. PubMed ID: 26492540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD).
    McEwen LN; Bilik D; Johnson SL; Halter JB; Karter AJ; Mangione CM; Subramanian U; Waitzfelder B; Crosson JC; Herman WH
    Diabetes Care; 2009 Jun; 32(6):971-6. PubMed ID: 19228862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' impact on improving outcomes in patients with type 2 diabetes mellitus.
    Pepper MJ; Mallory N; Coker TN; Chaki A; Sando KR
    Diabetes Educ; 2012; 38(3):409-16. PubMed ID: 22523190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Adherence to Insulin Initiation Recommendations at a Suburban Family Medicine Clinic.
    Harris KB; Olin JL
    Am J Ther; 2016; 23(6):e1542-e1546. PubMed ID: 26720168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.
    Pantalone KM; Wells BJ; Chagin KM; Ejzykowicz F; Yu C; Milinovich A; Bauman JM; Kattan MW; Rajpathak S; Zimmerman RS
    Diabetes Care; 2016 Sep; 39(9):1527-34. PubMed ID: 27519447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.